Data spanning the past 90 days through January 02, 2026 reveals that Biocryst Pharmaceuticals's three principal insider shareholders consist of Chief Executive Officer Jon P Stonehouse (1.36Mn shares), President And Cco Charles K Gayer (952.58K shares), Chief Legal Officer Alane P Barnes (398.75K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jon P Stonehouse | Chief Executive Officer | 1,363,429 | 23 Dec, 2025 |
| Charles K Gayer | President And Cco | 952,583 | 23 Dec, 2025 |
| Alane P Barnes | Chief Legal Officer | 398,751 | 23 Dec, 2025 |
| Anthony Doyle | Chief Financial Officer | 377,867 | 23 Dec, 2024 |
| Helen M. Thackray | Chief R&D Officer | 377,318 | 02 Apr, 2025 |
| Yarlagadda S Babu | Chief Discovery Officer | 298,541 | 16 Nov, 2022 |
| Babar Ghias | Chief Financial Officer | 268,700 | 19 Dec, 2025 |
| Robert Alexander Ingram | 100,198 | 02 Mar, 2023 | |
| Nancy J Hutson | 99,138 | 16 Jun, 2025 | |
| Vincent Milano | 91,219 | 02 Dec, 2025 | |
| Steve Aselage | 72,659 | 14 Jun, 2024 | |
| Kenneth B Jr Lee | 68,863 | 15 Jun, 2023 | |
| Theresa Heggie | 65,352 | 15 Aug, 2025 | |
| Alan G Levin | 64,271 | 16 Jun, 2025 | |
| Amy E Mckee | 41,790 | 02 Dec, 2025 | |
| William P Sheridan | Chief Medical Officer | 37,954 | 14 Mar, 2022 |
| George B Abercrombie | 36,431 | 14 Jun, 2024 | |
| Machelle Sanders | 30,642 | 17 Nov, 2025 | |
| Steven K Galson | 24,991 | 16 Jun, 2025 | |
| Steven Frank | 17,618 | 02 Dec, 2025 | |
| Michael L Jones | Exec. Director And Finance Pao | 16,653 | 21 Dec, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Dec, 2025 | Jon P Stonehouse | Common Stock | D | 61,793 | $7.41 | 1,323,429 | D | F |
| 19 Dec, 2025 | Alane P Barnes | Common Stock | D | 16,902 | $7.41 | 420,524 | D | F |
| 19 Dec, 2025 | Charles K Gayer | Common Stock | D | 11,477 | $7.41 | 878,350 | D | F |
| 22 Dec, 2025 | Charles K Gayer | Common Stock | A | 14,142 | $3.22 | 892,492 | D | M |
| 22 Dec, 2025 | Alane P Barnes | Common Stock | D | 21,773 | $7.65 | 398,751 | D | S |
| 22 Dec, 2025 | Charles K Gayer | Common Stock | A | 10,091 | $5.04 | 902,583 | D | M |
| 22 Dec, 2025 | Charles K Gayer | Common Stock | A | 50,000 | $5.51 | 952,583 | D | M |
| 18 Dec, 2025 | Jon P Stonehouse | Common Stock | D | 20,000 | $0.00 | 1,385,222 | D | G |
| 18 Dec, 2025 | Jon P Stonehouse | Common Stock | A | 10,000 | $0.00 | 40,000 | I | G |
| 18 Dec, 2025 | Jon P Stonehouse | Common Stock | A | 10,000 | $0.00 | 40,000 | I | G |
| 17 Dec, 2025 | Alane P Barnes | Common Stock | A | 121,700 | $0.00 | 437,426 | D | A |
| 17 Dec, 2025 | Babar Ghias | Common Stock | A | 121,700 | $0.00 | 268,700 | D | A |
| 17 Dec, 2025 | Charles K Gayer | Common Stock | A | 471,000 | $0.00 | 889,827 | D | A |
| 12 Dec, 2025 | Alane P Barnes | Common Stock | D | 8,540 | $7.57 | 336,936 | D | F |
| 12 Dec, 2025 | Jon P Stonehouse | Common Stock | D | 27,368 | $7.57 | 1,405,222 | D | F |
| 12 Dec, 2025 | Charles K Gayer | Common Stock | D | 8,181 | $7.57 | 418,827 | D | F |
| 15 Dec, 2025 | Alane P Barnes | Common Stock | D | 21,210 | $7.65 | 315,726 | D | S |
| 01 Dec, 2025 | Alane P Barnes | Common Stock | A | 91,004 | $3.22 | 507,156 | D | M |
| 01 Dec, 2025 | Alane P Barnes | Common Stock | D | 91,004 | $7.10 | 416,152 | D | S |
| 02 Dec, 2025 | Alane P Barnes | Common Stock | D | 50,906 | $7.21 | 365,246 | D | S |